Progress in abdominal organ transplantation

Medical Science Monitor

Volumn 17, Issue 12, 2011, Pages

  Kosieradzki, Maciej ^a   Lisik, Wojciech ^a   Rowiński, Wojciech ^a,b   Małkowski, Piotr ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b UNIVERSITY OF WARMIA AND MAZURY IN OLSZTYN   (Poland)

Author keywords

Intestines transplantation; Kidney transplantation; Liver transplantation; Pancreas transplantation; Pancreatic islets transplantation

Indexed keywords

CALCINEURIN INHIBITOR; CICLOHEXAL; CORTICOSTEROID; CYCLOSPORIN; CYCLOSPORIN A; EQUORAL; EVEROLIMUS; EZETIMIBE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LYMPHOCYTE ANTIBODY; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; TACROLIMUS; UNCLASSIFIED DRUG;

ACUTE GRAFT REJECTION; ARTICLE; DEEP VEIN THROMBOSIS; DYSLIPIDEMIA; GRAFT DYSFUNCTION; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTESTINE TRANSPLANTATION; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MUCORMYCOSIS; ORGAN PRESERVATION; ORGAN TRANSPLANTATION; PANCREAS ISLET; PANCREAS TRANSPLANTATION;

EID: 82755168712     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.882119     Document Type: Article

References (95)

1. El-Agroudy AE, Wafa EW, Sabry AA et al: The health of elderly living kidney donors after donation. Ann Transplant, 2009; 14(2): 13-19
2. Shrestha A, Basarab-Horwath C, McKane W et al: Quality of life following live donor renal transplantation: a single centre experience. Ann Transplant, 2010; 15(2): 5-10
3. Nickkholgh A, Frey E, Krenzel C et al: The need for vigilance in extended criteria donors with a past history of malignancy: a case report and review of literature. Ann Transplant, 2011; 16(1): 75-79
4. Caban A, Budzinski G, Oczkowicz G et al: Factors determining changes in concentrations of pro-inflammatory markers in blood serum in the initial period after kidney transplantation from dead donor. Ann Transplant, 2009; 14(4): 10-13
5. Sulikowski T, Domanski L, Zietek Z et al: The effect of preservation solutions UW and EC on the expression of renin I, angiotensinogen and angiotensin I-converting enzyme genes in rat kidney. Ann Transplant, 2011; 16(3): 108-13
6. Hanusch C, Hauser C, Geisler A et al: Reduction of oedema formation after preconditioning with dopamine in an isolated rat lung model is mediated by adrenergic receptors. Ann Transplant, 2011; 16(3): 97-107
7. Grzelak P, Kurnatowska I, Sapiecha M et al: Ultrasonographic evaluation of disturbances in the perfusion of renal graft parenchyma as a result of acute occlusion of supernumerary arteries-a new application for contrast-enhanced ultrasonography. Ann Transplant, 2011; 16(3): 23-29
8. Grzelak P, Szymczyk K, Strzelczyk J et al: Perfusion of kidney graft pyramids and cortex in contrast-enhanced ultrasonography in the determination of the cause of delayed graft function. Ann Transplant, 2011; 16(1): 48-53
9. Krol R, Chudek J, Karkoszka H et al: Apoptosis of tubular epithelial cells in preimplantation biopsies of kidney grafts with immediate, slow and delayed function. Ann Transplant, 2011; 16(3): 17-22
10. Kwiatkowski A, Wszola M, Kosieradzki M et al: The early and long term function and survival of kidney allografts stored before transplantation by hypothermic pulsatile perfusion. A prospective randomized study. Ann Transplant, 2009; 14(1): 14-17
11. Kwiatkowski A, Wszola M, Perkowska-Ptasinska A et al: Influence of preservation method on histopathological lesions of kidney allografts. Ann Transplant, 2009; 14(1): 10-13
12. Irish WD, Katz E: Cold machine perfusion or static cold storage of kidneys: why the debate continues. Am J Transplant, 2010; 10(9): 1955-56
13. Moers C, Smits JM, Maathuis MH et al: Machine perfusion or cold storage in deceased-donor kidney transplantation. N Engl J Med, 2009; 360(1): 7-19
14. Watson CJ, Wells AC, Roberts RJ et al: Cold machine perfusion versus static cold storage of kidneys donated after cardiac death: a UK multicenter randomized controlled trial. Am J Transplant, 2010; 10(9): 1991-99
15. Wszola M, Kwiatkowski A, Latek M et al: Long term medical and economical benefit of machine perfusion (MP) kidney storage in comparison to cold storage (CS). Ann Transplant, 2009; 14(2): 24-29
16. Halawa A: The early diagnosis of acute renal graft dysfunction: a challenge we face. The role of novel biomarkers. Ann Transplant, 2011; 16(1): 90-98
17. Goldstein MJ, Ying A, Dikman S et al: Forecasting Delayed Renal Allograft Function Prior to Transplantation. Am J Transplant, 2011, 11(Suppl. s2): 213
18. Fulton C, McGregor T, Forbes TL et al: Catheter-directed thrombolysis with tPA to restore renal function after iliac venous thrombosis post-renal transplantation. Ann Transplant, 2011; 16(1): 61-65
19. Einollahi B, Lessan-Pezeshki M, Aslani J et al: Two decades of experience in Mucormycosis after kidney transplantation. Ann Transplant, 2011; 16(3): 44-48
20. Kaden J, May G, Volp A, Wesslau C: Improved long-term survival after intra-operative single high-dose ATG-Fresenius induction in renal transplantation: a single centre experience. Ann Transplant, 2009; 14(3): 7-17
21. Schenker P, Ozturk A, Vonend O et al: Single-dose thymoglobulin induction in living-donor renal transplantation. Ann Transplant, 2011; 16(2): 50-58
22. Nutescu EA, Shapiro NL: Ezetimibe: a selective cholesterol absorption inhibitor. Pharmacotherapy, 2003; 23(11): 1463-74
23. Rodriguez-Ferrero ML, Anaya F: Ezetimibe in the treatment of uncontrolled hyperlipidemia in kidney transplant patients. Transplant Proc, 2008; 40(10): 3492-95
24. Niemczyk M, Paczek L: Ezetimibe in sirolimus-associated hyperlipidemia: to add or not to add to statins? Ann Transplant, 2011; 16(3): 132-34
25. van Gelder T: European society for organ transplantation advisory committee recommendations on generic substitution of immunosuppressive drugs. Transpl Int, 2011; 24(12): 1135-41
26. Momper JD, Ridenour TA, Schonder KS et al: The impact of conversion from prograf to generic tacrolimus in liver and kidney transplant recipients with stable graft function. Am J Transplant, 2011; 11(9): 1861-67
27. Klintmalm GB: Immunosuppression, generic drugs and the FDA. Am J Transplant, 2011; 11(9): 1765-66
28. Kahn D, Muller E, Pascoe M: Safe conversion to cicloral, a generic cylosporine, in both stable and de novo renal transplant recipients. Saudi J Kidney Dis Transpl, 2010; 21(3): 426-32
29. Durlik M, Paczek L, Rutkowski B et al: The efficacy and safety of ciclosporin (Equoral(R) capsules after renal transplantation: A multicentre, open-label, phase IV clinical trial. Ann Transplant, 2010; 15(3): 51-59
30. Niemczyk M, Paczek L: Generic formulation of Cyclosporine A, Equoral(R), in de novo kidney transplant recipients: five-year followup. Ann Transplant, 2011; 16(2): 59-62
31. Abdallah TB, Ounissi M, Cherif M et al: The role of generics in kidney transplant: mycophenolate mofetil 500 versus mycophenolate: 2-year results. Exp Clin Transplant, 2010; 8(4): 292-96
32. Abdulnour HA, Araya CE, Dharnidharka VR: Comparison of generic tacrolimus and Prograf drug levels in a pediatric kidney transplant program: brief communication. Pediatr Transplant, 2010; 14(8): 1007-11
33. Helderman JH, Kang N, Legorreta AP, Chen JY: Healthcare costs in renal transplant recipients using branded versus generic ciclosporin. Appl Health Econ Health Policy, 2010; 8(1): 61-68
34. Basu A, Falcone J, Dvorchik I et al: Outcomes of renal transplantation in recipients with peak panel reactive antibody >30% under tacrolimus-based immunosuppression. Ann Transplant, 2011; 16(3): 5-13.
35. Kozlowski T, Andreoni K: Limitations of rituximab/IVIg desensitization protocol in kidney transplantation; is this better than a tincture of time? Ann Transplant, 2011; 16(2): 19-25
36. Bradley JA, Baldwin WM, Bingaman A et al: Antibody-mediated rejection-an ounce of prevention is worth a pound of cure. Am J Transplant, 2011; 11(6): 1131-39
37. Sutherland DE, Gruessner RW, Dunn DL et al: Lessons learned from more than 1,000 pancreas transplants at a single institution. Ann Surg, 2001; 233(4): 463-501
38. Gruessner AC: 2011 update on pancreas transplantation: comprehensive trend analysis of 25,000 cases followed up over the course of twenty-four years at the International Pancreas Transplant Registry (IPTR). Rev Diabet Stud, 2011; 8(1): 6-16
39. Fridell JA, Joseph Tector A, Mangus RS et al: A new vascular approach to the modified multivisceral graft procurement. Clin Transplant, 2009; 23(6): 784-87
40. Cruz RJ Jr: Single-staple technique for pancreas allograft procurement. Ann Transplant, 2010; 15(2): 71-73
41. Suermann A, Vonend O, Schenker P et al: Plasma complement 3d levels in the early phase after pancreas transplantation. Ann Transplant, 2009; 14(3): 29-35
42. Ziaja J, Krol R, Chudek J et al: Intra-abdominal infections after simultaneous pancreas-kidney transplantation. Ann Transplant, 2011; 16(3): 36-43
43. Vantyghem MC, Balavoine AS, Caiazzo R et al: Diabetes cell therapy: a decade later. Minerva Endocrinol, 2011; 36(1): 23-39
44. Tchervenivanov N, Metrakos P, Kokugawa Y, Rosenberg L: Submucosal transplantation of pancreatic islets. Transplant Proc, 1994; 26(2): 680-81
45. Tchervenivanov N, Yuan S, Lipsett M et al: Morphological and functional studies on submucosal islet transplants in normal and diabetic hamsters. Cell Transplant, 2002; 11(6): 529-37
46. Caiazzo R, Gmyr V, Hubert T et al: Evaluation of alternative sites for islet transplantation in the minipig: interest and limits of the gastric submucosa. Transplant Proc, 2007; 39(8): 2620-23
47. Echeverri GJ, McGrath K, Bottino R et al: Endoscopic gastric submucosal transplantation of islets (ENDO-STI): technique and initial results in diabetic pigs. Am J Transplant, 2009; 9(11): 2485-96
48. Wszola M, Berman A, Fabisiak M et al: TransEndoscopic Gastric SubMucosa Islet Transplantation (eGSM-ITx) in pigs with streptozotocine induced diabetes-technical aspects of the procedure-preliminary report. Ann Transplant, 2009; 14(2): 45-50
49. Ng VL, Fecteau A, Shepherd R et al: Outcomes of 5-year survivors of pediatric liver transplantation: report on 461 children from a north american multicenter registry. Pediatrics, 2008; 122(6): e1128-35
50. Lodhi SA, Lamb KE, Meier-Kriesche HU: Solid organ allograft survival improvement in the United States: the long-term does not mirror the dramatic short-term success. Am J Transplant, 2011; 11(6): 1226-35
51. Alamo JM, Barrera L, Marin LM et al: Results of liver transplantation with donors older than 70 years: a case-control study. Transplant Proc, 2011; 43(6): 2227-29
52. Schmeding M, Sauer I, Hartwig K et al: Aging of the liver graft and functional quality in the absence of recurrent disease: a 10 year histological follow-up. Ann Transplant, 2010; 15(1): 5-13
53. Northup PG, Abecassis MM, Englesbe MJ et al: Addition of adult-toadult living donation to liver transplant programs improves survival but at an increased cost. Liver Transpl, 2009; 15(2): 148-62
54. Markiewicz-Kijewska M, Kalicinski P, Teisseyre J et al: Liver transplantation with ABO incompatible graft under immunoadsorption protocol-case report. Ann Transplant, 2010; 15(4): 68-71
55. Gelas T, McKiernan PJ, Kelly DA et al: ABO-incompatible pediatric liver transplantation in very small recipients: Birmingham's experience. Pediatr Transplant, 2011; 15(7): 706-11
56. Hernadez-Alejandro R, Wall W, Jevnikar A et al: Organ donation after cardiac death: donor and recipient outcomes after the first three years of the Ontario experience. Can J Anaesth, 2011; 58(7): 599-605
57. Dominguez-Gil B, Haase-Kromwijk B, Van Leiden H et al: Current situation of donation after circulatory death in European countries. Transpl Int, 2011; 24(7): 676-86
58. Tariciotti L, Rocha C, Perera MT et al: Is It Time to Extend Liver Acceptance Criteria for Controlled Donors After Cardiac Death? Transplantation, 2011; 92(10): 1140-46
59. Karp SJ, Johnson S, Evenson A et al: Minimising cold ischaemic time is essential in cardiac death donor-associated liver transplantation. HPB (Oxford), 2011; 13(6): 411-16
60. Bartlett A, Vara R, Muiesan P et al: A single center experience of donation after cardiac death liver transplantation in pediatric recipients. Pediatr Transplant, 2010; 14(3): 388-92
61. Loggi E, Micco L, Ercolani G et al: Liver Transplantation from Hepatitis B Surface Antigen Positive Donors: A Safe Way to Expand the Donor Pool. J Hepatol, 2011
62. Yataco M, Bonatti H, Machicao V et al: Long term survival and complications after liver transplantation in patients with chronic hepatitis B. Ann Transplant, 2010; 15(2): 27-34
63. Jaeck D, Boudjema K, Audet M et al: Auxiliary partial orthotopic liver transplantation (APOLT) in the treatment of acute liver failure. J Gastroenterol, 2002, 37(Suppl.13): 88-91
64. Mochizuki S, Kawashita Y, Eguchi S et al: Liver repopulation by transplanted hepatocytes in a rat model of acute liver failure induced by carbon tetrachloride and a partial hepatectomy. Ann Transplant, 2010; 15(4): 49-55
65. Wesson RN, Cameron AM: Stem cells in acute liver failure. Adv Surg, 2011; 45: 117-30
66. Rozga J, Malkowski P: Artificial liver support: quo vadis? Ann Transplant, 2010; 15(4): 92-101
67. Memon I, Klein CL: Impact of hepatorenal syndrome and liver transplantation. Curr Opin Organ Transplant, 2011; 16(3): 301-5
68. Sedra AH, Strum E: The role of intraoperative hemodialysis in liver transplant patients. Curr Opin Organ Transplant, 2011; 16(3): 323-25
69. Scouras NE, Matsusaki T, Boucek CD et al: Portopulmonary hypertension as an indication for combined heart, lung, and liver or lung and liver transplantation: literature review and case presentation. Liver Transpl, 2011; 17(2): 137-43
70. Guarrera JV, Henry SD, Samstein B et al: Hypothermic machine preservation in human liver transplantation: the first clinical series. Am J Transplant, 2010; 10(2): 372-81
71. Dondero F, Paugam-Burtz C, Danjou F et al: A randomized study comparing IGL-1 to the University of Wisconsin preservation solution in liver transplantation. Ann Transplant, 2010; 15(4): 7-14
72. Eurich D, Seehofer D, Veltzke-Schlieker W et al: Successful endoscopic and surgical management of non-anastomotic biliary strictures after liver transplantation-case report. Ann Transplant, 2009; 14(1): 47-51
73. Koch RO, Kaser A: Genetic insights into non-anastomotic biliary strictures after orthotopic liver transplantation. Liver International, 2011; 31(8): 1065-67
74. Czuprynska MM, Wawrzynowicz-Syczewska M, Jureczko L et al: Preemptive administration of recombinant factor VII (rVIIa) in patients transplanted due to fulminant Wilson's disease. Ann Transplant, 2010; 15(3): 7-10
75. Trzebicki J, Flakiewicz E, Kosieradzki M et al: The use of thromboelastometry in the assessment of hemostasis during orthotopic liver transplantation reduces the demand for blood products. Ann Transplant, 2010; 15(3): 19-24
76. Hong JC, Yersiz H, Busuttil RW: Where are we today in split liver transplantation? Curr Opin Organ Transplant, 2011; 16(3): 269-73
77. Clavien PA, Lesurtel M, Bossuyt PM et al: Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report. Lancet Oncol, 2011
78. Ekong UD: The long-term liver graft and protocol biopsy: do we want to look? What will we find? Curr Opin Organ Transplant, 2011; 16(5): 505-8
79. Knight SR, Morris PJ: Steroid sparing protocols following nonrenal transplants; the evidence is not there. A systematic review and metaanalysis. Transpl Int, 2011; 24(12): 1198-207
80. Sanchez-Fueyo A: Hot-topic debate on tolerance: Immunosuppression withdrawal. Liver Transpl, 2011, 17(Suppl.3): S69-73
81. Haddad EM, McAlister VC, Renouf E et al: Cyclosporin versus tacrolimus for liver transplanted patients. Cochrane Database Syst Rev, 2006(4): CD005161
82. Dopazo C, Rodriguez R, Llado L et al: Successful conversion from twicedaily to once-daily tacrolimus in liver transplantation: observational multicenter study. Clin Transplant, 2011
83. Romero FA, Razonable RR: Infections in liver transplant recipients. World J Hepatol, 2011; 3(4): 83-92
84. van de Berg PJ, Heutinck KM, Raabe R et al: Human cytomegalovirus induces systemic immune activation characterized by a type 1 cytokine signature. J Infect Dis, 2010; 202(5): 690-99
85. Pacholczyk M, Lagiewska B, Lisik W et al: Invasive fungal infections following liver transplantation-risk factors, incidence and outcome. Ann Transplant, 2011; 16(3): 14-16
86. U.S. Department of Health and Human Services HRaSA, Healthcare Systems Bureau, Division of Transplantation, Rockville, MD.: 2009 Annual Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1994-2008. In.: U.S. Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation, Rockville, MD.; 2009
87. Beath S, Pironi L, Gabe S et al: Collaborative strategies to reduce mortality and morbidity in patients with chronic intestinal failure including those who are referred for small bowel transplantation. Transplantation, 2008; 85(10): 1378-84
88. Wunderlich H, Brockmann JG, Voigt R et al: DTG procurement guidelines in heart beating donors. Transpl Int, 2011; 24(7): 733-57
89. Matsumoto CS, Kaufman SS, Fishbein TM: Inclusion of the colon in intestinal transplantation. Curr Opin Organ Transplant, 2011; 16(3): 312-15
90. Wu G, Selvaggi G, Nishida S et al: Graft-versus-host disease after intestinal and multivisceral transplantation. Transplantation, 2011; 91(2): 219-24
91. Ueno T, Fukuzawa M: Current status of intestinal transplantation. Surg Today, 2010; 40(12): 1112-22
92. Abu-Elmagd KM, Costa G, Bond GJ et al: Five hundred intestinal and multivisceral transplantations at a single center: major advances with new challenges. Ann Surg, 2009; 250(4): 567-81
93. Adeyi OA, Costa G, Abu-Elmagd KM, Wu T: Rotavirus infection in adult small intestine allografts: a clinicopathological study of a cohort of 23 patients. Am J Transplant, 2010; 10(12): 2683-89
94. Mercer DF: Hot topics in postsmall bowel transplantation: noninvasive graft monitoring including stool calprotectin and plasma citrulline. Curr Opin Organ Transplant, 2011; 16(3): 316-22
95. Farmer DG, Venick RS, Colangelo J et al: Pretransplant predictors of survival after intestinal transplantation: analysis of a single-center experience of more than 100 transplants. Transplantation, 2010; 90(12): 1574-80